Wataru Obara

37PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNavigation and position fixing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 03, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study.

|May 06, 2026
Essential Renal Bleeding Presenting as Persistent Unilateral Hematuria Successfully Treated With Factor XIII Replacement Therapy: A Case Report.

|Apr 08, 2026
Dermatopathological Findings of an Erythema Multiforme-Like Drug Eruption During Enfortumab Vedotin Plus Pembrolizumab Therapy for Metastatic Urothelial Carcinoma: A Case Report.

Ryunosuke Murofushi, Yoichiro Kato, Takashi Seo

|Oct 13, 2025
Editorial Comment to Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers.

Wataru Obara, Daichi Tamura

|Sep 26, 2025
Pulmonary Embolism Associated with Olaparib in BRCA2-Mutated Prostate Cancer: A Case Report.

Shuhei Ishii, Shigekatsu Maekawa, Fumiko Amano

|Sep 24, 2025
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab.

Tokiyoshi Tanegashima, Masaki Shiota, Shusuke Akamatsu

Pageof 7

Frequent Collaborators

9 joint publications

Shigekatsu Maekawa

7 joint publications

Daiki Ikarashi

6 joint publications

Mitsugu Kanehira

3 joint publications

Norihiko Tsuchiya